AP-1 ± activator protein 1 ± was discovered over a dozen years ago through a happy marriage between transcription factor research and tumor virology. AP-1 was identi®ed as a TPA-inducible transcription factor activity binding to the enhancers of SV40 and the metallothioneine gene. Soon after, Jun was discovered as a novel oncoprotein of the avian sarcoma virus with identical binding properties to the yeast transcriptional regulator GCN4, and the Fos-associated p39 protein was identi®ed as the product of the cellular Jun gene. Fos itself, a nuclear phosphoprotein, was ®rst isolated as the cellular homologue of two viral v-fos oncogenes, both of which induce osteosarcomas in mice and rats. This was the basis of our present textbook knowledge that Fos and Jun are partners and the two proteins constitute the prototypic components of the AP-1 complex. Meanwhile in vertebrates several family members of Fos and Jun were identi®ed, which all are induced in cells following growth factor addition. These groundbreaking ®ndings catalysed countless investigations into the gene and protein structures of the ever increasing number of partners of Fos and Jun, and many studies were initiated regarding the regulation and function of the family members as well as the relationship between transcription deregulation and oncogenesis.
When compiling such a review volume, one contemplates whether this is the right time for such an undertaking. I believe it is, since the last decade has provided many important insights into AP-1 functions based on the breakthroughs in structural biology, biochemistry and modern molecular genetics. I was greatly stimulated to embark on this activity by the formulation of the European TMR network on`The AP-1 Transcription Factor: Function and Regulation of AP-1 Family Members in Cell Proliferation and Dierentiation'. This successful European program lasted over the past 4 years and achieved a remarkable exchange of information, knowledge and reagents, and led to fruitful collaborations between the members of the various European national laboratories working on AP-1.
What is so special about AP-1? There is a high degree of evolutionary conservation between dierent species regarding the gene structure of these factors. In yeast, members of the AP-1 family of proteins are required for the transcriptional response to various stress conditions. Moreover, studies in the model organism Drosophila melanogaster demonstrate that a wide range of biological processes, such as tissue closure, patterning of the eye, gut and wing, as well as apoptosis, are controlled by single D-jun and D-Fos proteins. There is even recent evidence that a DNA binding domain similar to Jun might be functional in C. elegans. Needless to say there are more family members and there is greater complexity in the mammalian model organism, the mouse. With powerful genetic tools to generate transgenic strains carrying speci®cally designed mutant AP-1 alleles, it became clear that modulating AP-1 activity can aect many aspects of the physiology of the cell. Therefore, what is the real function and how important is AP-1 in vertebrates, where it is expressed in many cell types? Is AP-1 a relevant transcription factor complex in human development and disease? Are the basic mechanisms discovered in yeast and¯ies relevant for mice and man? I believe that the similarities but also the dierences between species boundaries are equally interesting and that they teach us important lessons regarding the underlying molecular pathways. Never- theless, it is a possibility that the ®eld will soon be exhausted from data in model organisms and the time is now right to extend studies on AP-1 function to human development and disease.
There is general agreement from data across species that AP-1 senses environmental information and translates it into expression of speci®c genes. How is this determined? Everybody would agree that by virtue of their oncogenic origin, activation of AP-1 is mostly correlated with proliferation and tumor formation, and with induction of apoptosis. However, as you can read in this volume, AP-1 components can also act as potential tumor suppressors. A role for AP-1 in cell dierentiation independent of proliferation is less clear, since we cannot assume at all that the absence of a particular cell-type would invoke a block in dierentiation. De®nitive studies using in vivo and in vitro systems will be necessary to clarify this point.
It is the diversity of responses catalysed by AP-1 as well as the very dierent biological functions of the individual components which are fascinating. At the same time it is frustrating, because`the unexpected' makes hypothesis-driven research unpredictable with lots of surprising results. There is a plethora of AP-1 interacting proteins which are certainly determinants of speci®c biological responses. How many are there and do we have to consider several hundred AP-1 factors involved in the signal interpretation leading to the aforementioned diversity? The answer is probably YES! It will likely be the task for the future to solve this complexity and single out the activating factors with broad speci®city as well as the ones with unique functions. Recent data have shown that there may be functional equivalence between AP-1 family members in vertebrates, implying that the regulation of a particular factor is more important than its protein structure. However, this is in con¯ict with data in some transgenic mice demonstrating that a broad increase in AP-1 activity through overexpression of individual components is without overt consequences for the animal and that even complex developmental processes caused by the lack of AP-1 components can be fully rescued by deregulated AP-1 activity.
This special issue features contributions by many leaders in the ®eld of AP-1 and as exempli®ed by the reviews that follow, we anticipate for future years an exciting journey of great discoveries in many areas. Some of them are outlined in the individual chapters, in which I have not eliminated repetitions to keep them in an independently readable form and to allow the dierent points of view to be made. Will genomics, proteomics and also chemistry solve the enigma of transcriptional speci®city of this multiprotein complex? While the achievements have been great, signi®cant challenges remain in the dierent model organisms. However, I think it is conceivable that soon we will be able to know all genes positively or negatively regulated by AP-1 in a given cell type or model system. With the advent of genechip technology, we anticipate to eventually ®nd the relevant genes controlling both the oncogenic and anti-oncogenic phenotype, and also the genes acting during development. The role of AP-1 will certainly be further elucidated in the organs most responsive to the environment such as the skin and the immune system, and major eorts are underway in neurobiology. We have excellent evidence that the amount and diversity of interacting partners as well as the crosstalk to other transcription factors can be synergistic or antagonistic, and that AP-1 is able to function as a primary determinant of the immune response and will likely play a role in a variety of immune diseases.
It will be exciting to watch the ®eld move into dierent directions with the one major goal of understanding how to modulate AP-1 activity to be bene®cial for the organism and the cells. Will we ever seriously consider AP-1, its mode of activation and the individual partners as feasible drug targets to ®ght diseases? We are aware that there is a ®ne line between AP-1 being a physiological player, an activator of neuro-regeneration and an eector of neuro-degeneration. In other words, AP-1 plays a central role in the decision whether a given cell divides, stays alive or dies and such decisions may have signi®cance for the lifespan of the organism; and that is after all what matters and`keeps us ticking'. We rationalize that from a better understanding of these fundamental principles about cells using AP-1 as an environmental biosensor that we will perhaps learn to improve the cell's response to harmful external in¯uences. It may be possible to keep cells intact when desirable, but to kill them when necessary and to develop strategies to combat not only our daily stress, but to ®ght diseases, in particular cancer. It is clear that partner-relationships matter and that coming together as speci®c AP-1 dimers or promiscuous AP-1 complexes at the right time in the right place certainly also matters in biology because these relationships will determine the outcome of the`magic switch' turned on by AP-1.
